ALS study Webinar

Did you miss the ALS study Webinar arranged by Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS), on Wednesday 23rd January, 2019?

A phase 3 Trial (REFALS) studying the effect of oral Levosimendan (ODM-109) on Respiratory Function in patients with ALS (Amyotrophic Lateral Sclerosis) was discussed at the webinar.

REFALS is currently ongoing and has completed the recruitment of 450 patients across sites in the U.S., Canada, EU and Australia.

SPEAKERS:

Dr. Merit Cudkowicz (Massachusetts General Hospital)

Dr. Ammar Al-Chalabi (King´s College London)

Please use this link to watch the REFALS study webinar